Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1.

Medwid S, Li MMJ, Knauer MJ, Lin K, Mansell SE, Schmerk CL, Zhu C, Griffin KE, Yousif MD, Dresser GK, Schwarz UI, Kim RB, Tirona RG.

Drug Metab Dispos. 2019 Aug;47(8):832-842. doi: 10.1124/dmd.119.087619. Epub 2019 May 23.

PMID:
31123035
2.

Synthesis, Characterization, and Evaluation of Near-IR Boron Dipyrromethene Bioconjugates for Labeling of Adenocarcinomas by Selectively Targeting the Epidermal Growth Factor Receptor.

Kaufman NEM, Meng Q, Griffin KE, Singh SS, Dahal A, Zhou Z, Fronczek FR, Mathis JM, Jois SD, Vicente MGH.

J Med Chem. 2019 Apr 11;62(7):3323-3335. doi: 10.1021/acs.jmedchem.8b01746. Epub 2019 Mar 25.

3.

Synthesis and in vitro PDT evaluation of new porphyrins containing meso-epoxymethylaryl cationic groups.

Carneiro J, Gonçalves A, Zhou Z, Griffin KE, Kaufman NEM, Vicente MDGH.

Lasers Surg Med. 2018 Jul;50(5):566-575. doi: 10.1002/lsm.22824. Epub 2018 Apr 25.

4.

Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetes.

Chen YC, Colvin ES, Griffin KE, Maier BF, Fueger PT.

Diabetologia. 2014 Oct;57(10):2066-75. doi: 10.1007/s00125-014-3311-z. Epub 2014 Jul 4.

5.

Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.

Manns MP, Neuhaus P, Atkinson GF, Griffin KE, Barnass S, Vollmar J, Yeang Y, Young CL; Famciclovir Liver Transplant Study Group.

Transpl Infect Dis. 2001 Mar;3(1):16-23.

PMID:
11429035
6.

Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.

Wedemeyer H, Böker KH, Pethig K, Petzold DR, Flemming P, Tillmann HL, Vollmar J, Bastürk M, Goldmann E, Griffin KE, Haverich A, Manns MP.

Transplantation. 1999 Nov 27;68(10):1503-11.

PMID:
10589947
7.
8.

Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins.

Griffin KE, Cooper CE, Slocombe B.

J Chemother. 1989 Jul;1(4 Suppl):71-3. No abstract available.

PMID:
16312309
9.

Comparative activities in vitro of amoxycillin/clavulanic acid and ampicillin/sulbactam.

Masters PJ, Cooper CE, Griffin KE, Slocombe B, Sutherland R.

J Chemother. 1989 Jul;1(4 Suppl):67-9. No abstract available.

PMID:
16312307
11.

Antibacterial activity of resolved temocillin epimers.

White AR, Cooper CE, Griffin KE, Slocombe B.

J Antimicrob Chemother. 1986 Sep;18(3):335-43.

PMID:
3533885
12.

Antibacterial activity of ticarcillin in the presence of clavulanate potassium.

Sutherland R, Beale AS, Boon RJ, Griffin KE, Slocombe B, Stokes DH, White AR.

Am J Med. 1985 Nov 29;79(5B):13-24.

PMID:
3878080
13.

Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR.

Antimicrob Agents Chemother. 1985 Apr;27(4):495-8.

14.

Temocillin. In vitro antibacterial activity.

Slocombe B, Cooper CE, Griffin KE, White AR.

Drugs. 1985;29 Suppl 5:49-56.

PMID:
3849425
15.

Supplemental Content

Loading ...
Support Center